Bruker has announced the planned discontinuation of the IsoSpark and IsoLight platforms. Customers with questions about transition options and last-time-buy opportunities should contact their Bruker sales representative.
In this Webinar we discuss:
Learn how gut microbiota shapes extra-intestinal anti-cancer immune response.
Discover how gut microbiota interventions promote responses to immunotherapy.
See how ICT promotes gut microbiota translocation into MLN, Spleen, TDLN & tumor.